WHWK(Whitehawk Therapeutics, Inc.) · 财务报表

WHWK(Whitehawk Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$14.00M$15.22M$24.35M$25.98M$7.14M
毛利润$14.00M$13.88M$21.55M$22.96M$6.38M
营业利润−$111.22M−$62.68M−$71.93M−$67.46M−$114.40M
净利润−$110.09M−$60.51M−$65.77M−$63.69M−$20.60M
经营现金流−$22.42M−$49.64M−$59.66M−$59.55M−$97.43M
自由现金流−$22.47M−$50.08M−$63.63M−$61.20M−$97.98M
摊薄每股收益$-12.41$-2.69$-2.44$-2.36$-0.33

Whitehawk Therapeutics, Inc. WHWK